FACULTAD DE CIENCIAS BIOMÉDICAS Y DE LA SALUD

Faculty

Foto de FACULTAD DE CIENCIAS BIOMÉDICAS Y DE LA SALUD

Foto de Centre Antoine Lacassagne

Centre Antoine Lacassagne

Niza, Francia

Publications in collaboration with researchers from Centre Antoine Lacassagne (5)

2020

Capivasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer: The PAKT trial
Journal of Clinical Oncology

2015

Afatinib alone or afatinib plus vinorelbine versus investigator's choice of treatment for HER2-positive breast cancer with progressive brain metastases after trastuzumab, lapatinib, or both (LUX-Breast 3): A randomised, open-label, multicentre, phase 2 trial
The Lancet Oncology, Vol. 16, Núm. 16, pp. 1700-1710
Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer
New England Journal of Medicine, Vol. 372, Núm. 8, pp. 724-734

2013

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): Overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study
The Lancet Oncology, Vol. 14, Núm. 6, pp. 461-471

2005

Cancer-related anemia: Pathogenesis, prevalence and treatment
Oncology